Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Efficacy of VL-UVA1 Versus NB-UVB on Inducing Repigmentation in Subjects With Generalized Vitiligo

NCT05238077 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT05238077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05238077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Efficacy of VL-UVA1 Versus NB-UVB on Inducing Repigmentation in Subjects With Generalized Vitiligo
Lead sponsor
Henry Ford Health System
Phase
Not applicable
Overall status
Terminated
Start date
February 26, 2018
Completion date
June 2, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

generalized vitiligo